期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 35, 期 11, 页码 39-47出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2014.09.002
关键词
rapamycin; mTOR; autophagy; Beclin 1; aggregation; neurodegenerative disease
资金
- FONDECYT [1140549, 11121524]
- Millennium Institute [P09-015-F]
- CONICYT [USA2013-0003, PAI 7912010006]
- ECOS-CONICYT [C13S02]
- Michael J. Fox Foundation for Parkinson's Research
- ALS Therapy Alliance
- Muscular Dystrophy Association
- Alzheimer's Disease Association
- Ring Initiative [ACT1109]
- FONDEF [D11I1007]
- Foundation COPEC-UC
The most prevalent neurodegenerative disorders involve protein Autophagy is becoming an attractive target to treat neurodegenerative disorders through the selective degradation of abnormally folded proteins by the lysosomal pathway. However, accumulating evidence indicates that autophagy impairment at different regulatory steps may contribute to the neurodegenerative process. Thus, a complex scenario is emerging where autophagy may play a dual role in neurodegenerative diseases by causing the downstream effect of promoting the degradation of misfolded proteins and an upstream effect where its deregulation perturbs global proteostasis, contributing to disease progression. Challenges in the future development of therapeutic strategies to target the autophagy pathway are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据